Beyond Biotech - the podcast from Labiotech

As September 8 is Stand Up To Cancer Day, one area of promising research lies in cytokine-based drugs, which have the potential to activate T cells against tumors. Historically, toxicity from systemi…

On this week’s podcast, to recognize Blood Cancer Awareness Month, we have a conversation with Affimed's CMO, Andreas Harstrick, to talk about blood cancers, and what Affimed is doing to tackle blood…

On this week’s podcast, we have a conversation with Dr Jack Scannell, CEO of Etheros Pharmaceuticals Corp. Scannell recently co-authored a paper on the expenses related to clinical research and the f…

Since its inception in 2012, World Lung Cancer Day has been observed every year on August 1 in order to raise awareness of lung cancer issues and magnify the need for more lung cancer research fundin…

To learn about pepteins, we had a conversation with Christian Schwarz, CEO and co-founder of Numaferm.  

Numaferm is a German biotech company, specializing in the production of pepteins, which are an …

2:02 Labiotech.eu news
2:51 MinervaX 

To recognize International Group B Strep Awareness Month in July, we had a conversation with MinervaX CEO, Per Fischer. 

MinervaX is a privately-held Danish biotech…

2;00  Labiotech news
3:36  BaseLaunch

In today's episode, we have a conversation with Stephan Emmerth, director business development and operations at biotech startup incubator BaseLaunch, and Sai Redd…

1:54  Labiotech news
3:48  NodThera

This week, we’re talking about inflammasome inhibitors with Alan Watt, CEO of NodThera.

The company recently announced it is the first to show a reduction in neuroinf…

2:55  Labiotech news
4:27  Mablink Bioscience

On the podcast this week, we have a conversation about antibody-drug conjugates with Pejvack Motlagh, who was recently announced as the chief medical offic…

2:38  Labiotech news
4:23  APSFA
20:59 University of Michigan

June is Antiphospholipid Syndrome (APS) Awareness Month. 

APS is a rare autoimmune disorder in which the body recognizes certain normal compo…

1:13  Labiotech news
3:09  Lund Spring Symposium
27:36 Sapient

Sapient

Sapient is an end-to-end biomarker discovery organization dedicated to accelerating the mapping of circulating chemistries in humans…

2:45  Labiotech news
4:58  Orgenesis
22:35 CellProthera
38:22 Terumo Blood and Cell Technologies
52:02 BioSenic

The International Society for Cell & Gene Therapy (ISCT), the global society of more than 3,…

1:24  Labiotech news
3:40  BC Platforms

A conversation about precision medicine with Tero Silvola, CEO at BC Platforms. We also discuss the acquisition of 4Pharma.

The acquisition expands BCP’s global s…

1:18  Labiotech news
3:37  BioInvent

BioInvent International AB, a Swedish biotech company focused on the discovery and development of novel and first-in-class immune-modulatory antibodies for cancer i…

1:33  Labiotech news
3:31  Daiichi Sankyo/AstraZeneca

The companies Daiichi Sankyo and AstraZeneca have worked together for several years.

This week’s podcast is sponsored by Daiichi Sankyo and AstraZen…

4:26  Labiotech news
6:36  Medidata
21:43 Bill & Melinda Gates Research Institute

This week’s podcast is sponsored by Jubilant Biosys.

May 20 is International Clinical Trials Day.

ECRIN,  the European Cli…

This week’s podcast is sponsored by Quantoom.

International MPS Awareness Day

May is the big month when it comes to awareness - there are almost 100 awareness months, weeks, and days being marked.

Some …

3:32  Labiotech news
5:33  Lupus interview

This week’s podcast is sponsored by Lonza.

May is Lupus Awareness Month, and to talk about lupus with us this week on the podcast are Katherine Tran, senior gl…

2:13  Labiotech news
5:17  bit.bio

This week’s podcast is sponsored by Scientist.com.

The mainstream news in the past couple of months has picked up on artificial intelligence (AI). Not so much its uses…